glp-1 for ckd Design and discovery of a highly potent ultralong-acting and glucagon co-agonist attenuating renal fibrosis Role of GLP-1 Agonists &

Incretins are released after eating and augment the secretion of insulin released from pancreatic beta cells of the islets of Langerhans by a blood-glucose-dependent mechanism

doi: 10.1007/BF03262460

Athauda D, Gulyani S, Karnati HK, Li Y, Tweedie D, Mustapic M, et al

Restaurants shouldnt chase GLP-1-friendly labels as a marketing gimmick

Within the past few years, GLP-1 prescriptions for non-diabetes patients have risen by more than 700%

Coronary microvascular dysfunction in HFpEF Understanding the relationship between coronary microvascular dysfunction (CMD) and heart failure with preserved ejection fraction (HFpEF) is crucial